Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

• Main Authors: Zhou, J., Bi, C., Janakakumara, J.V., Liu, S.-C., Chng, W.-J., Tay, K.-G., Poon, L.-F., Xie, Z., Palaniyandi, S., Chen, C.-S., Yu, H., Glaser, K.B., Albert, D.H., Davidsen, S.K.
• Other Authors: PHYSIOLOGY
• Format: Article
• Published: 2011
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/26991
• Institution: National University of Singapore

10.1182/blood-2008-05-156422